GB0723972D0 - Use of vitamin B12 - Google Patents

Use of vitamin B12

Info

Publication number
GB0723972D0
GB0723972D0 GBGB0723972.6A GB0723972A GB0723972D0 GB 0723972 D0 GB0723972 D0 GB 0723972D0 GB 0723972 A GB0723972 A GB 0723972A GB 0723972 D0 GB0723972 D0 GB 0723972D0
Authority
GB
United Kingdom
Prior art keywords
vitamin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0723972.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Queen Mary University of London
Original Assignee
Queen Mary and Westfiled College University of London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Queen Mary and Westfiled College University of London filed Critical Queen Mary and Westfiled College University of London
Priority to GBGB0723972.6A priority Critical patent/GB0723972D0/en
Publication of GB0723972D0 publication Critical patent/GB0723972D0/en
Priority to PCT/GB2008/004023 priority patent/WO2009071905A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
GBGB0723972.6A 2007-12-07 2007-12-07 Use of vitamin B12 Ceased GB0723972D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0723972.6A GB0723972D0 (en) 2007-12-07 2007-12-07 Use of vitamin B12
PCT/GB2008/004023 WO2009071905A2 (en) 2007-12-07 2008-12-05 Use of thiolatocobalamins as regulators/selective promoters of inducible and constitutive nitric oxide synthases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0723972.6A GB0723972D0 (en) 2007-12-07 2007-12-07 Use of vitamin B12

Publications (1)

Publication Number Publication Date
GB0723972D0 true GB0723972D0 (en) 2008-01-23

Family

ID=39016338

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0723972.6A Ceased GB0723972D0 (en) 2007-12-07 2007-12-07 Use of vitamin B12

Country Status (2)

Country Link
GB (1) GB0723972D0 (en)
WO (1) WO2009071905A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3730144A4 (en) 2017-12-21 2021-09-01 Osaka University Agent for treatment of nervous system disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004526793A (en) * 2001-04-25 2004-09-02 コバルツ リミテッド Methods for treating or preventing functional vitamin B12 deficiency in an individual, and medical compositions for use in the methods
US6894033B2 (en) * 2001-06-11 2005-05-17 Transition Therapeutics Inc. Combination therapies using vitamin B12 and therapeutic agents for treatment of viral, proliferative and inflammatory diseases
US20030017135A1 (en) * 2001-07-17 2003-01-23 Cruz Tony F. Pharmaceutical compositions comprising vitamin B12 and interferon for treating multiple sclerosis
WO2007070983A1 (en) * 2005-12-22 2007-06-28 Apollo Life Sciences Limited Transdermal delivery of pharmaceutical agents

Also Published As

Publication number Publication date
WO2009071905A3 (en) 2009-08-20
WO2009071905A2 (en) 2009-06-11

Similar Documents

Publication Publication Date Title
HK1149756A1 (en) Isoxazolo-pyridine derivatives
IL205753A0 (en) Isoxazolo-pyridazine derivatives
EP2120569A4 (en) Spirochromanon derivatives
HK1138198A1 (en) Stabilization of vitamin b12
IL202020A0 (en) Spiroindolinone derivatives
IL202830A0 (en) Indazolamide derivatives
IL205755A0 (en) Isoxazolo-pyrazine derivatives
IL200618A0 (en) Aza-pyridopyrimidinone derivatives
HK1139129A1 (en) 18f-labelled folates 18f-
IL201248A0 (en) 18f - labelled folates
IL202667A0 (en) Isoxazole-imidazole derivatives
PL2245028T3 (en) 5-aminocyclylmethyl-oxazolidin-2-one derivatives
HK1207857A1 (en) 18f-labelled folates 18f-
EP2133347A4 (en) 1-biarylazetidinone derivatives
HK1137187A1 (en) Use of tocopherol
HK1141009A1 (en) Sulfonyl-quinoline derivatives
IL202159A0 (en) Piperidine-amide derivatives
HK1146276A1 (en) Thiadiazinone derivatives
GB0723972D0 (en) Use of vitamin B12
EP2204368A4 (en) 4-sulfonylpiperidine derivatives
GB201114396D0 (en) Location of basesation
GB0705204D0 (en) Uses of (S)-clenbuterol
ZA200904356B (en) Use of tocopherol
GB0703712D0 (en) Rollator
HU0700417D0 (en) Sulfonyl-quinoline derivatives

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)